UBS lifts target for Cellnex stock to EUR 71.00
Published on 10/14/2026 at 17:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- UBS raised its Cellnex target from EUR 61.00 to EUR 71.00 on October 9, 2026.
- Cellnex reported EUR 1.99 billion in revenue for the first half of 2026, up 5.00 percent organically.
- Cellnex stock costs EUR 24.42 at Lang & Schwarz on October 14, 2026 at 5:06 p.m. CEST, 0.37 percent below the Xetra close of October 13, 2026, and 25.34 percent below the 52-week high.
- Cellnex is scheduled to report its next quarterly results on November 5, 2026.
UBS raised its recommendation on Cellnex from Neutral to Buy and lifted its price target from EUR 61.00 to EUR 71.00 on October 9, 2026, according to El Espanol. Cellnex stock was trading at EUR 24.42 at Lang & Schwarz on October 14, 2026 at 5:06 p.m. CEST, 0.37 percent below the Xetra close of October 13, 2026 at EUR 24.51.
Revenue growth supports cash flow
Cellnex reported consolidated revenue of EUR 1.99 billion for the first half of 2026, with organic revenue growth of 5.00 percent year over year. The company also reported adjusted EBITDA growth of 6.40 percent and EBITDA after leases of EUR 1.23 billion.
Free cash flow increased to EUR 301.00 million in the first half of 2026 from EUR 19.00 million in the first half of 2025. Cellnex said on July 30, 2026 that its additional EUR 200.00 million share buyback would bring planned shareholder remuneration for 2026 to EUR 1.00 billion.
Stock remains below its yearly high
The EUR 24.42 Lang & Schwarz price stood between Cellnex's 52-week low of EUR 21.84 and high of EUR 32.71 on October 14, 2026. It was 25.34 percent below the high and 11.81 percent above the low, while the stock's year-to-date performance was minus 12.83 percent as of October 9, 2026.
Trading volume for Cellnex was 397,963 shares against an average of 1,360,525 shares in the latest finance quote. The price position gives the UBS target a clear numerical implication: EUR 71.00 is 190.75 percent above the Lang & Schwarz price, although the target belongs to a different valuation perspective than the intraday quote.
Valuation and next reporting date
Cellnex had a market capitalization of EUR 16.2 billion as of October 14, 2026. The quoted trailing P/E was minus 47.45, while the next quarterly results are listed for November 5, 2026 by TickerLandia.
Comparison with peers
Cellnex (BME, EUR): minus 0.37 percent, P/E minus 47.45, market capitalization EUR 16.2 billion
American Tower (NYSE, USD): minus 0.96 percent, P/E 24.42, market capitalization USD 82.8 billion
SBA Communications (NASDAQ, USD): minus 1.70 percent, P/E 19.20, market capitalization USD 19.0 billion
Trading level and investor calendar
Cellnex's current euro quote, its 52-week placement and the scheduled November 5, 2026 results date give investors three measurable reference points for the stock. The next results will provide a fresh test of the first-half revenue growth and cash flow trend.
The further course of trading is shown by the continuously updated real-time quote of Cellnex stock.
Cellnex market data
- Company: Cellnex Telecom, S.A.
- ISIN: ES0105066007
- Ticker: CLNX.MC
- Primary exchange: BME
- Price Lang & Schwarz (as of October 14, 2026, 5:06 p.m. CEST): EUR 24.42
- Change versus Xetra close: minus 0.37 percent
- Xetra close (October 13, 2026): EUR 24.51
- Market capitalization: EUR 16.2 billion (as of October 14, 2026)
- 52-week range: EUR 21.84-EUR 32.71 (as of October 14, 2026)
- Sector / Industry: Communication Services / Diversified Telecommunication Services
- Index membership: IBEX 35
- Next earnings date: November 5, 2026
Market context: Market report IBEX 35.
